Mycologics
)
Mycologics is developing MycoV-43™, a technology delivering a new line of biofungicides with chemical-equivalent disease control. MycoV-43 targets fungal pathogens through a novel mode of action while boosting plants' systemic disease response, providing broad-spectrum protection sustainably. Backed by $1.45+M from USDA and NSF SBIR programs, NCGA, Maryland and NC state programs, AgLaunch, and NC Biotechnology Center, Mycologics has demonstrated 50-70% disease suppression in field trials. The company seeks $2M seed for biomanufacturing scale-up, trials, and EPA registration before commercial launch.
Category: Crop Protection
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
)
)
)
)